|
M.S. Novikova, O.M. Koteshkova, M.B. Antsiferov
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
|
№4 / 2022
|
|
S.S. Apetov, V.V. Apetova
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
|
№4 / 2022
|
|
L.Yu. Morgunov
Type 3 diabetes mellitus: is there a chance to become famous?
|
№4 / 2022
|
|
A.D. Akulova (1), Yu.S. Zhulina (1), V.V. Rozhkova (1), E.Yu. Martynova (2), Yu.E. Poteshkin (1)
Problem of treatment adherence in patients with type 2 diabetes mellitus
|
№4 / 2022
|
|
|
№3 / 2022
|
|
E.G. Bykova (1), A.S. Shkurat (2), M.I. Ivanova (1), S.A. Boldueva (1), M.V. Rozhdestvenskaya (1)
Case of successful treatment of Dressler’s syndrome
|
№3 / 2022
|
|
A.V. Tarantsova
Features of the management and follow-up of a “difficult” comorbid elderly patient with COVID-19 complications: a clinical case
|
№3 / 2022
|
|
A.A. Rimkevichus, R.Kh. Lyukmanov, E.V. Shalimanova, R.K. Shikhkerimov, E.V. Gnedovskaya, N.A. Suponeva
First experience with botulinum toxin type A in central prosoparesis
|
№3 / 2022
|
|
D.I. Trukhan, D.S. Ivanova
Drug safety in real clinical practice: focus on protective therapy
|
№3 / 2022
|
|
E.V. Ponevezhskaya (1), E.A. Petrova (1), M.A. Savina (2), E.A. Koltsova (1)
Risk factors for the development of apathy after cerebral stroke taking into account comorbid psychopathology
|
№3 / 2022
|
|
A.N. Komarov
An integrated approach to the correction of pain syndrome and lumbar spine dysfunction in patients with chronic spondylarthrosis in the exacerbation phase
|
№3 / 2022
|
|
T.E. Morozova (1), D.A. Shatskiy (1), T.B. Andruschishina (1), M.V. Lukina (1), V.P. Fisenko (1), D.A. Sychev (2)
Efficacy and tolerability of ketoprofen in patients with coronary artery disease in the postoperative period after cardiac surgery, depending on the comorbid status
|
№3 / 2022
|
Русский
